Notice: This company has been marked as potentially delisted and may not be actively trading. ERYTECH Pharma (ERYP) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Phaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketFebruary 21, 2024 | finanznachrichten.deRoyalty Pharma PLC Class A RPRXJanuary 19, 2024 | morningstar.comErytech Pharma S.A.: Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXMJune 28, 2023 | finanznachrichten.dePhaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXMJune 28, 2023 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital - June 26, 2023June 27, 2023 | finance.yahoo.comERYTECH and PHERECYDES announce merger and name change to PHAXIAM TherapeuticsJune 26, 2023 | finance.yahoo.comERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023June 23, 2023 | finance.yahoo.comErytech Pharma S.A.: ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuitJune 20, 2023 | finanznachrichten.deTech, Pharma Stocks Lead European Equities Higher in Thursday TradingJune 15, 2023 | msn.comERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes PharmaJune 14, 2023 | finance.yahoo.comErytech's Battle With Activist Investor Echoes As Pherecydes Pharma Merger Vote Comes CloserJune 13, 2023 | benzinga.comMonthly information related to total number of voting rights and shares composing the share capital _May 31, 2023June 13, 2023 | finance.yahoo.comErytech Pharma S.A.: ERYTECH Responds to Akkadian's DisinformationJune 12, 2023 | finanznachrichten.deERYTECH Responds to Akkadian’s DisinformationJune 12, 2023 | finance.yahoo.comErytech Pharma S.A.: ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with PherecydesJune 5, 2023 | finanznachrichten.deERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with PherecydesJune 5, 2023 | finance.yahoo.comERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023May 24, 2023 | finance.yahoo.comPharma Stocks Lead European Equities Sharply Lower in Wednesday TradingMay 24, 2023 | msn.comPHERECYDES Announces the Availability of the Exemption Document Relating to the Proposed Combination With Erytech PharmaMay 23, 2023 | businesswire.comERYTECH announces the availability of the exemption document relating to the proposed combination with PherecydesMay 23, 2023 | finance.yahoo.comPharma Stocks Lead European Equities Modestly Lower in Tuesday TradingMay 23, 2023 | msn.comEuropean Equities Rise in Friday Trading, Poised to End Week HigherMay 19, 2023 | msn.comPharma Stocks Weigh Down European Equities in Wednesday TradingMay 17, 2023 | msn.comMonthly information related to total number of voting rights and shares composing the share capital _May 15, 2023May 16, 2023 | finance.yahoo.comPharma Stocks, Vodafone Lead European Equities Lower in Tuesday TradingMay 16, 2023 | msn.comErytech Pharma S.A.: ERYTECH Provides Update on the Announced Combination with PHERECYDESMay 15, 2023 | finanznachrichten.deERYTECH Provides Update on the Announced Combination with PHERECYDESMay 15, 2023 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital _April 30, 2023May 12, 2023 | finance.yahoo.comEuropean Equities Traded as American Depositary Receipts Lower Again in Wednesday US TradingMay 12, 2023 | msn.comErytech Pharma S.A.: ERYTECH Provides Business and Financial Update for the First Quarter of 2023May 9, 2023 | finanznachrichten.deMicro Cap Bid Up Right Before Opening BellMay 9, 2023 | theglobeandmail.comERYTECH Provides Business and Financial Update for the First Quarter of 2023May 9, 2023 | finance.yahoo.comERYTECH Provides Business and Financial Update for the First Quarter of 2023May 9, 2023 | finance.yahoo.comErytech Pharma S.A.: ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital MarketApril 17, 2023 | finanznachrichten.deERYTECH receives approval to transfer its listing to Nasdaq Capital MarketApril 17, 2023 | seekingalpha.comERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital MarketApril 17, 2023 | finance.yahoo.comPharma Stocks Lead European Equities Lower Friday Trading, But Index Poised to End Week HigherApril 14, 2023 | msn.comPharma Stocks Lead European Equities Higher Wednesday TradingApril 12, 2023 | msn.comMonthly information related to total number of voting rights and shares composing the share capital _March 31, 2023April 12, 2023 | finance.yahoo.comPharma Stocks Lead European Equities Higher in Thursday TradingApril 6, 2023 | msn.comFinancial, Pharma Stocks Lift European Equities in Tuesday TradingApril 6, 2023 | msn.comPherecydes Pharma Announces Its 2022 Annual Financial Results and Specifies Its Development Plan For 2023April 1, 2023 | morningstar.comErytech Pharma S.A.: ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022March 22, 2023 | finanznachrichten.deERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022March 22, 2023 | finance.yahoo.comFinancial, Pharma Stocks Drag European Equities Sharply Lower in Tuesday TradingMarch 7, 2023 | msn.comMonthly information related to total number of voting rights and shares composing the share capital _February 28, 2023March 6, 2023 | finance.yahoo.comFinancial Stocks Lead European Equities Lower in Thursday TradingMarch 2, 2023 | msn.comErytech Pharma S.A.: ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage TherapiesFebruary 16, 2023 | finanznachrichten.deERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage TherapiesFebruary 15, 2023 | finance.yahoo.comEuropean Equities Flat After Strong Start in Tuesday TradingFebruary 14, 2023 | msn.com Get ERYTECH Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ERYP and its competitors with MarketBeat's FREE daily newsletter. Email Address A “Thank You Gift” From Pres. Trump - Genius (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide ERYP Media Mentions By Week ERYP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ERYP News Sentiment▼0.000.50▲Average Medical News Sentiment ERYP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ERYP Articles This Week▼00▲ERYP Articles Average Week Get ERYTECH Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ERYP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SGMO News PRME News FDMT News ALEC News DNA News VALN News ENGN News JSPR News KOD News ITOS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ERYP) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 ETF for monthly incomeWe just found the #1 ETF for monthly income. This outlier is paying a huge 22% dividend... And you could...Investors Alley | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ERYTECH Pharma S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share ERYTECH Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.